# Functions and mechanisms of transcriptional coactivator OCA-B in B cell development and lymphomagenesis

> **NIH NIH R01** · ROCKEFELLER UNIVERSITY · 2020 · $737,527

## Abstract

PROJECT SUMMARY
 A functional immune system is central to human health and, at the same time, alterations of normal lymphoid
developmental programs can lead to immune deficiencies, autoimmune diseases and a variety of lymphomas.
Germinal centers (GCs) are microanatomical structures formed in secondary lymphoid organs during antigen-
stimulated immune responses. GCs are the sites of B cell maturation through clonal expansion, somatic
hypermutation, and affinity-mediated selection -- and therefore play a critical role in differentiation of antibody
secreting cells and memory B cells. OCA-B is a unique transcriptional coactivator that is highly expressed in GC
B cells and GC-derived lymphomas such as diffuse large B cell lymphoma and Burkitt’s lymphoma. In vivo
studies have demonstrated that OCA-B is essential for both antigen-dependent B cell differentiation (including
GC formation) and normal expression of secondary immunoglobulin genes. However, little is known about the
exact role of OCA-B in normal GC formation and GC-derived lymphoma progression. In addition, the mechanism
by which OCA-B regulates its target genes is also unclear. In addressing these issues, our preliminary studies
have demonstrated (i) a functional occupancy of OCA-B on distal enhancers, in particular the large locus control
region (LCR) of the BCL6 gene that encodes a master regulator of GC formation; (ii) direct interactions of OCA-
B with the MED1 subunit of the Mediator coactivator complex and with a GC-specific transcription factor (MEF2B)
important for BCL6 expression and (iii) a B cell-intrinsic Oca-B dependency for GC B cell differentiation in vivo.
 Based on our previous OCA-B studies and recent preliminary data, we hypothesize that a predominant role
of OCA-B in GC formation involves activation of BCL6 through its distal enhancer region by recruiting and
concentrating transcription factors and cofactors, including chromatin/epigenetic factors, that facilitate enhancer-
promoter interactions. We also hypothesis that OCA-B plays a critical role in GC-derived lymphomagenesis. To
address these issues, we will investigate (i) the function and mechanism of action of OCA-B, through interactions
with MED1/Mediator and MEF2B, on the BCL6 LCR/super-enhancer in both ex vivo GC B and lymphoma cells,
(ii) the mechanism of action of OCA-B-dependent transcriptional coactivation through rigorous biochemical in
vitro transcription assays; (iii) the mechanism of action of OCA-B in GC B cell differentiation in vivo, including
identification of key target genes and regulatory networks; (iv) the role of OCA-B in B cell lymphoma progression
in vivo. We will use complementary biochemical, genomic, bioinformatic, genetic, gene-editing, cell-based and
in vivo (mouse model) approaches. Completion of these aims will advance our understanding of the molecular
mechanism of action of OCA-B in GC-specific transcriptional regulation, GC B cell differentiation, and GC-
derived B cell lymphomagenesi...

## Key facts

- **NIH application ID:** 9865891
- **Project number:** 1R01AI148387-01
- **Recipient organization:** ROCKEFELLER UNIVERSITY
- **Principal Investigator:** ROBERT G ROEDER
- **Activity code:** R01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $737,527
- **Award type:** 1
- **Project period:** 2019-12-12 → 2024-11-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/9865891

## Citation

> US National Institutes of Health, RePORTER application 9865891, Functions and mechanisms of transcriptional coactivator OCA-B in B cell development and lymphomagenesis (1R01AI148387-01). Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/grant/nih/9865891. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*